AC-262536

AC-262536 is an agonist of Androgen Receptor used in studies of Hormone Signaling. It is especially relevant in cancer, endocrinology, and immunology models, where defined compound exposure can be linked to ligand-dependent transcriptional programs and endocrine regulation.

By activating Androgen Receptor, AC-262536 can be used to examine ligand-dependent transcriptional programs and endocrine regulation. The nuclear receptor annotation adds relevance to reporter-gene, receptor-binding, and transcriptional assays, together with downstream-response mapping in the same experimental setting. In cancer, endocrinology, and immunology models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving Androgen Receptor
• Pathway perturbation studies connected to Hormone Signaling
• Agonist-response and downstream signaling studies
• Reporter-gene, receptor-binding, and transcriptional assays

Overall, AC-262536 is appropriate when a defined chemical perturbant is needed to connect Androgen Receptor with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cancer, endocrinology, and immunology models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.